10/30/2026 | Press release | Archived content
October 30, 2026 | Net Health
2 min read
Acquisition strengthens Net Health's wound care strategy, adding evidence-based intelligence to WoundExpert and extending it to any EHR through Tissue Analytics
PITTSBURGH, Pa., Oct. 30, 2026 - Net Health, an AI-native specialty platform serving clinicians across the care continuum, today announced the acquisition of key clinical technologies from Tissue Health Plus, LLC, a subsidiary of Sanara MedTech Inc. The acquisition includes clinical decision support (CDS) assets, clinical data, research, AI/ML imaging technologies, and value-based care analytics. Net Health plans to deliver additional intelligent and evidence-based CDS experiences within its industry-leading wound care platforms, WoundExpert and Tissue Analytics.
"Specialty knowledge is what makes technology useful at the point of care, and this acquisition brings more of it to our wound care solutions. That's the kind of investment we will keep making across the platform, because intelligence is only useful when it sits inside the workflow clinicians already use," said Patrick Rooney, interim CEO of Net Health.
The acquisition accelerates Net Health's continued investment in intelligence capabilities that can improve clinical user experience and wound care outcomes regardless of care venue. The goal is to put specialty expertise in the hands of every clinician who assesses a wound, including nurses who often work without a wound specialist nearby. The acquired assets include more than 1,000 clinical rules authored by market-leading wound experts and grounded in graded clinical research, wound care guidelines, and CMS coverage determinations.
"Wounds happen in every setting, everywhere care is delivered," said John Gresham, Division President of Wound Care at Net Health. "Wound care teams need intelligent decision support in the workflow they already use. This technology helps us deliver it from the hospital and clinic to the home, reducing the documentation burden and helping address the shortage of wound care providers in the market."
For over 30 years, Net Health has gathered specialty knowledge shaped by human expertise and informed by patient outcomes. Today, this depth of knowledge is the foundation for an AI-native specialty platform that delivers intelligence to clinicians across the care continuum, enabling them to be present with patients during the moments that matter. Net Health is a trusted source of specialty solutions for more than 34,000 healthcare organizations and is a portfolio company of The Carlyle Group, Level Equity, and Silversmith Capital Partners.